These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 15617850)

  • 1. Improved drug delivery to cancer cells: a method using magnetoliposomes that target epidermal growth factor receptors.
    Kullberg M; Mann K; Owens JL
    Med Hypotheses; 2005; 64(3):468-70. PubMed ID: 15617850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Photochemically stimulated drug delivery increases the cytotoxicity and specificity of EGF-saporin.
    Weyergang A; Selbo PK; Berg K
    J Control Release; 2006 Mar; 111(1-2):165-73. PubMed ID: 16466823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of targeted therapy with paclitaxel incorporated into EGF-conjugated nanoparticles.
    Shimada T; Ueda M; Jinno H; Chiba N; Wada M; Watanabe J; Ishihara K; Kitagawa Y
    Anticancer Res; 2009 Apr; 29(4):1009-14. PubMed ID: 19414339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Principles of magnetodynamic chemotherapy.
    Babincová M; Leszczynska D; Sourivong P; Babinec P; Leszczynski J
    Med Hypotheses; 2004; 62(3):375-7. PubMed ID: 14975506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delivery of sodium borocaptate to glioma cells using immunoliposome conjugated with anti-EGFR antibodies by ZZ-His.
    Feng B; Tomizawa K; Michiue H; Miyatake S; Han XJ; Fujimura A; Seno M; Kirihata M; Matsui H
    Biomaterials; 2009 Mar; 30(9):1746-55. PubMed ID: 19121537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peptide ligand-mediated liposome distribution and targeting to EGFR expressing tumor in vivo.
    Song S; Liu D; Peng J; Sun Y; Li Z; Gu JR; Xu Y
    Int J Pharm; 2008 Nov; 363(1-2):155-61. PubMed ID: 18692120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EGF-receptor targeted liposomes with boronated acridine: growth inhibition of cultured glioma cells after neutron irradiation.
    Kullberg EB; Wei Q; Capala J; Giusti V; Malmström PU; Gedda L
    Int J Radiat Biol; 2005 Aug; 81(8):621-9. PubMed ID: 16298943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heparin-binding epidermal growth factor-like growth factor isoforms and epidermal growth factor receptor/ErbB1 expression in bladder cancer and their relation to clinical outcome.
    Kramer C; Klasmeyer K; Bojar H; Schulz WA; Ackermann R; Grimm MO
    Cancer; 2007 May; 109(10):2016-24. PubMed ID: 17394193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apoptotic epidermal growth factor (EGF)-conjugated block copolymer micelles as a nanotechnology platform for targeted combination therapy.
    Lee H; Hu M; Reilly RM; Allen C
    Mol Pharm; 2007; 4(5):769-81. PubMed ID: 17867644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Guided molecular missiles for tumor-targeting chemotherapy--case studies using the second-generation taxoids as warheads.
    Ojima I
    Acc Chem Res; 2008 Jan; 41(1):108-19. PubMed ID: 17663526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolactin modulates phosphorylation, signaling and trafficking of epidermal growth factor receptor in human T47D breast cancer cells.
    Huang Y; Li X; Jiang J; Frank SJ
    Oncogene; 2006 Dec; 25(58):7565-76. PubMed ID: 16785991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective downregulation of EGF receptor and downstream MAPK pathway in human cancer cell lines by active components partially purified from the seeds of Livistona chinensis R. Brown.
    Huang WC; Hsu RM; Chi LM; Leu YL; Chang YS; Yu JS
    Cancer Lett; 2007 Apr; 248(1):137-46. PubMed ID: 16919867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EGF receptor-targeted synthetic double-stranded RNA eliminates glioblastoma, breast cancer, and adenocarcinoma tumors in mice.
    Shir A; Ogris M; Wagner E; Levitzki A
    PLoS Med; 2006 Jan; 3(1):e6. PubMed ID: 16318410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting the EGF receptor ectodomain in the context of cancer.
    Huang L; De Baetselier P; Beyaert R
    Expert Opin Ther Targets; 2009 Nov; 13(11):1347-61. PubMed ID: 19769546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidermal growth factor promotes epidermal growth factor receptor nuclear accumulation by a pathway dependent on cytoskeleton integrity in human breast cancer cells.
    Cortes-Reynosa P; Robledo T; Salazar EP
    Arch Med Res; 2009 Jul; 40(5):331-8. PubMed ID: 19766894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A cross-talk between the androgen receptor and the epidermal growth factor receptor leads to p38MAPK-dependent activation of mTOR and cyclinD1 expression in prostate and lung cancer cells.
    Recchia AG; Musti AM; Lanzino M; Panno ML; Turano E; Zumpano R; Belfiore A; Andò S; Maggiolini M
    Int J Biochem Cell Biol; 2009 Mar; 41(3):603-14. PubMed ID: 18692155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Control of cell motility by interaction of gangliosides, tetraspanins, and epidermal growth factor receptor in A431 versus KB epidermoid tumor cells.
    Park SY; Yoon SJ; Freire-de-Lima L; Kim JH; Hakomori SI
    Carbohydr Res; 2009 Aug; 344(12):1479-86. PubMed ID: 19559406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A cleavable molecular adapter reduces side effects and concomitantly enhances efficacy in tumor treatment by targeted toxins in mice.
    Fuchs H; Bachran C; Li T; Heisler I; Dürkop H; Sutherland M
    J Control Release; 2007 Feb; 117(3):342-50. PubMed ID: 17207883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Steroid receptor regulation of epidermal growth factor signaling through Src in breast and prostate cancer cells: steroid antagonist action.
    Migliaccio A; Di Domenico M; Castoria G; Nanayakkara M; Lombardi M; de Falco A; Bilancio A; Varricchio L; Ciociola A; Auricchio F
    Cancer Res; 2005 Nov; 65(22):10585-93. PubMed ID: 16288052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of heparin-binding EGF-like growth factor and activation of EGF receptor in imatinib mesylate-treated squamous carcinoma cells.
    Johnson FM; Saigal B; Donato NJ
    J Cell Physiol; 2005 Nov; 205(2):218-27. PubMed ID: 15887238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.